Preferred Label : immunotherapy, adoptive;
MeSH definition : Form of adoptive transfer where cells with antitumor activity are transferred to the
tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly
used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes
(TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et
al., Cancer, 1993, pp.305-7, 314);
MeSH synonym : adoptive immunotherapies; immunotherapies, adoptive cellular; immunotherapy, adoptive cellular; adoptive cellular immunotherapy; adoptive immunotherapy; immunotherapies, adoptive; cellular immunotherapy, adoptive; adoptive cellular immunotherapies; cellular immunotherapies, adoptive;
MeSH hyponym : CAR T-Cell Therapy; CAR T Cell Therapy; CAR T-Cell Therapies; T-Cell Therapies, CAR; T-Cell Therapy, CAR; Therapies, CAR T-Cell; Therapy, CAR T-Cell;
MeSH annotation : IM; do not use /util except by MeSH definition; for CAR T-Cell Therapy, coordinate with RECEPTORS, CHIMERIC ANTIGEN;
Wikipedia link : https://en.wikipedia.org/wiki/Adoptive immunotherapy;
Origin ID : D016219;
UMLS CUI : C0079613;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Indexing information
Record concept(s)
Related MeSH Supplementary Concept(s)
See also
Semantic type(s)
UMLS correspondences (same concept)
Form of adoptive transfer where cells with antitumor activity are transferred to the
tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly
used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes
(TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et
al., Cancer, 1993, pp.305-7, 314)
https://www.afmps.be/fr/news/les_medicaments_de_therapie_innovante_non_reglementes_presentent_de_graves_risques_pour_la
2025
false
false
false
Belgium
French
innovative therapies
risk
patient safety
pharmacovigilance note
Dendritic Cell Therapy
immunotherapy, adoptive
dendritic cells
legislation, drug
europe
belgium
---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-janvier-2024-8-11-janvier
2024
false
false
false
France
French
risk management
valproic acid
Male
Neurodevelopmental Disorders
Chimeric antigen receptor T-cell therapy
genetic therapy
Secondary Carcinoma
Chimeric Antigen Receptor Therapy
immunotherapy, adoptive
pharmacovigilance note
---
https://ansm.sante.fr/tableau-acces-derogatoire/yescarta-0-4-2-x-108-cellules-dispersion-pour-perfusion#
2024
false
false
false
France
French
axicabtagene ciloleucel
axicabtagene ciloleucel
biological products
Antineoplastic Agents, Immunological
Recurrent High Grade B-Cell Lymphoma
lymphoma, large B-Cell, diffuse
adult
Refractory High Grade B-Cell Lymphoma
drug information
immunotherapy, adoptive
antigens, CD19
---
https://www.has-sante.fr/jcms/p_3262244/fr/yescarta-axicabtagene-ciloleucel
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
axicabtagene ciloleucel
adult
lymphoma, large B-Cell, diffuse
mediastinal neoplasms
recurrence
Primary mediastinal (thymic) large B-cell lymphoma (disorder)
Primary Mediastinal Large B-Cell Lymphoma
infusions, intravenous
Anti-CD19 CAR T Cells Preparation
Recurrent Primary Mediastinal Large B-Cell Lymphoma
antigens, CD19
Receptors, Chimeric Antigen
t-lymphocytes
evaluation of the transparency committee
axicabtagene ciloleucel
antigens, CD19
immunotherapy, adoptive
immunotherapy, adoptive
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/avis-sur-laxicabtagene-ciloleucel-pour-le-traitement-des-lymphomes-a-grandes-cellules-b-recidivants-ou-refractaires.html
2019
false
true
false
false
Canada
Diffuse large B-cell lymphoma recurrent
Diffuse large B-cell lymphoma refractory
axicabtagene ciloleucel
technical report
axicabtagene ciloleucel
lymphoma, large B-Cell, diffuse
immunotherapy, adoptive
antigens, CD19
---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/bdc/e-docs/00/03/F9/68/resume.md?type=text.html
2003
France
French
melanoma
lymphocytes, tumor-infiltrating
melanoma
immunotherapy, adoptive
immunotherapy, adoptive
immunotherapy, adoptive
lymphocytes, tumor-infiltrating
journal article
french abstract
---